Connect your AI

Oscar Health OSCR Trading securities, cost

Trading securities, cost at other companies

UnitedHealth GroupUNH

——

Other financials

Income statement

Revenue$4.6B+52.6%

Operating income$704.1M+137%

Net income$679.0M+147%

EPS (diluted)$2.07+125%

Balance sheet

Cash & equivalents$4.8B+114%

Total debt$430.9M+43.7%

Total equity$1.7B+24.8%

Total assets$9.3B+59.0%

Cash flow

Operating cash flow$2.6B+198%

CapEx$8.8M-2.6%

Free cash flow$2.6B+200%

Valuation

Market cap$8.56B+4.0%

Enterprise value$4.16B-174%

P/S0.6×-0.2×

Profitability

Operating margin0.1%—

Net margin-0.3%—

FCF margin-8.2%—

Returns & leverage

Return on equity-2.6%—

Debt / equity0.3×0.0×

Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's trading securities, cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Oscar Health's trading securities, cost?: Oscar Health (OSCR) reported trading securities, cost of $3.91M in Q1 2026.
How has Oscar Health's trading securities, cost changed year-over-year?: Oscar Health's trading securities, cost increased by 62.3% year-over-year, from $2.41M to $3.91M.